Tuesday, October 17, 2017

Archive for the Category ‘Featured’

Apricus Clinical Pipeline Nears Groundbreaking FDA Catalysts Which Could Increase Market Cap Substantially

Apricus Clinical Pipeline Nears Groundbreaking FDA Catalysts Which Could Increase Market Cap Substantially

Flying under the radar from many retail and institutional investors and into the new year comes Apricus Bio, a company whose mere 50M market cap is substantially undervalued based on its large diverse product portfolio, healthy financial standing, and forward looking market possibilities. The company and its two wholly owned subsidiaries, NexMed and Bio-Quant, owns […]

Key Upcoming FDA Catalysts May Help Rebound ADVENTRX To New Highs

Key Upcoming FDA Catalysts May Help Rebound ADVENTRX To New Highs

ADVENTRX Pharmaceuticals (AMEX:ANX) is a company that is rarely mentioned among the bigger players, though this may soon change as it gains attention heading into its 2011 product pipeline catalysts. As it enters the new year, the stock seemed poised to make new 52-week highs as it announced the much anticipated positive 12-month results for […]

Insider Selling and Options Trading May Spell Troubles for Protalix (AMEX:PLX), (NASDAQ:OREX)

Insider Selling and Options Trading May Spell Troubles for Protalix (AMEX:PLX), (NASDAQ:OREX)

Small cap biotech investments with upcoming FDA catalysts has become one of the hottest new trends, especially due to the fact that it is easy to foresee or expect catalysts based on the use of FDA calendars, and general medical timelines on drug and clinical trials. Unlike other industries where new technologies in research and […]

Wikileaks Preparing Disclosure on US Bank Data (NYSE:XLF), (NYSE:BAC), (NYSE:GS), (NYSE:JPM), (NYSE:AIG), (NYSE:WFC)

Wikileaks Preparing Disclosure on US Bank Data (NYSE:XLF), (NYSE:BAC), (NYSE:GS), (NYSE:JPM), (NYSE:AIG), (NYSE:WFC)

Many investors, especially the bears that have been hiding for much of late 2010 and into 2011 will be smiling at the thoughts of a possible Wikileaks release to add fuel to the fire. Many sources are claiming Bank of America, however the way the economy has been the past few months, anything is possible […]

Is the Fast and Furious Selloff Finally Here? (NYSE:SDS), (NYSE:FAZ), (NYSE:QID), (NYSE:XLF), (NYSE:BAC), (NYSE:AIG)

Is the Fast and Furious Selloff Finally Here? (NYSE:SDS), (NYSE:FAZ), (NYSE:QID), (NYSE:XLF), (NYSE:BAC), (NYSE:AIG)

As of today, I will begin a daily market update on the (note sarcasm) economic recovery and the USA’s ability to survive one of the worst depressions in history, because afterall, according to many experts we’ve now passed that phase. I felt the Austin Powers villain, Dr. Evil picture perfectly suits the overlods that run […]

Osiris May Soon Become The World’s First Approved Stem Cell Therapy (NASDAQ:OSIR), (NASDAQ:IBB), (NYSE:XBI)

Osiris May Soon Become The World’s First Approved Stem Cell Therapy (NASDAQ:OSIR), (NASDAQ:IBB), (NYSE:XBI)

The stem cell market is slated to become $88.3 billion by 2014, with growth of well over 14.8% from now until then. This paves the way for potential revenues that border the imagination for any Wall Street analyst should any company become the first to see FDA approval. While at first thought this may sound […]

Three Equities Positioned To Stay Afloat During The Forthcoming Market Correction (NASDAQ:BPAX), (OTC:NEOP), (NYSE:FAZ)

Three Equities Positioned To Stay Afloat During The Forthcoming Market Correction (NASDAQ:BPAX), (OTC:NEOP), (NYSE:FAZ)

Ever since The New York Stock Exchange building opened on April 22, 1903, it has flawlessly followed a particular pattern that, even to this day, still stands: hope, greed, skepticism, followed by, fear, panic, despondency whereby the pattern is once again repeated by beginning with hope. It is a cycle that can either make or […]

Two Biotech Companies Poised For Gains As Call Options Boost Investor Sentiment (NASDAQ:CLDA), (NASDAQ:BPAX)

Two Biotech Companies Poised For Gains As Call Options Boost Investor Sentiment (NASDAQ:CLDA), (NASDAQ:BPAX)

In a day and age where uncertainty seems to rule the culture of the stock market world, call and put options have become increasingly popular in order to hedge a portfolio from a potential unforeseen event. Unfortunately, this is how most investors view options, however, many forget that it could also be used as a […]

Neoprobe Looks To Become A Major Player In The Oncology Market (OTC:NEOP), (NASDAQ:IBB), (NYSE:XBI), (NASDAQ:DEPO), (NASDAQ:AMRN), (NASDAQ:CORT)

Neoprobe Looks To Become A Major Player In The Oncology Market (OTC:NEOP), (NASDAQ:IBB), (NYSE:XBI), (NASDAQ:DEPO), (NASDAQ:AMRN), (NASDAQ:CORT)

Within the $40 trillion dollar US market, the biotechnology sector has become a hot investment option for those looking to hedge against a possible upcoming market correction. During the past six months, shares within the NASDAQ Bio Index (NASDAQ:IBB) are up 20.12%, while the S&P Bio Index (NYSE:XBI) matched those gains with 21.02%. This is […]

BioSante Attracts Institutional Investors Ahead of Key FDA Catalysts in 2011 (NASDAQ:BPAX), (NASDAQ:ETRM), (AMEX:LCI), (AMEX:YMI)

BioSante Attracts Institutional Investors Ahead of Key FDA Catalysts in 2011 (NASDAQ:BPAX), (NASDAQ:ETRM), (AMEX:LCI), (AMEX:YMI)

Following the Christmas break, shares of BioSante (NASDAQ:BPAX) soared more than 27% during Monday’s session on volume of 10.57M shares versus an average of 251,478, leaving investors hungry for the company’s potential in its upcoming FDA catalysts in early 2011, as highlighted by our previous article. All seemed well going into the next trading session, […]

Back to Top

Social Media Profiles

ADVERTISEMENT

BUSINESS NETWORKS

The New York Times logo CNN logo ABC logo CNBC logo